System Labs vs Trimi
Two GLP-1 desks, one scoreboard. We put System Labs and Trimi head-to-head on the published Brief Score — the same six factors, scored the same way.
The verdict
Trimi takes this head-to-head.
Trimi scores 89 to 59 on our six-factor Brief Score — A clean, all-in membership desk that publishes one price on both molecules nationwide and hasn't played the teaser-rate game.
That doesn't make System Labs a bad call — it's best for readers who want one predictable tirzepatide bill they can cancel next month, and who will read the "/first mo." on the $99 before budgeting around it — not readers who came for semaglutide, or who need to confirm their state before starting an intake. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| System Labs | Trimi | |
|---|---|---|
| Brief Score | 59/100 (C) | 89/100 (B+) |
| Semaglutide | Not offered — no semaglutide is sold here at any price | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) |
| Tirzepatide | $179/mo flat, month-to-month, the same at every dose — the $99 beside it is a first-month intro rate, not the ongoing one | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Newnew to the tracker, no prior reading | Stableprice stable |
System Labs: First reading, 8 August 2026. One rate, one cadence: $179 a month, flat, month-to-month, identical at every dose — the FAQ commits to it in those words and the buy box sells a single "Monthly Supply (All doses)" line. No three-, six- or twelve-month rung exists, so there is no prepay figure here to mistake for a monthly one. The $99 printed beside it is a first-month intro rate, labeled "/first mo." on the page and flagged as an intro in the lander's own commerce data; month two is $179. Tirzepatide only — no semaglutide is sold at any price.
Trimi: Membership rate held flat this cycle — both molecules disclosed up front, no first-month teaser.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.